We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$214M
AUM Growth
-$1.94M
Cap. Flow
-$12M
Cap. Flow %
-5.58%
Top 10 Hldgs %
39.29%
Holding
99
New
24
Increased
11
Reduced
21
Closed
34

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.98M
2
ABBV icon
AbbVie
ABBV
+$4.46M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$4.25M
4
HCA icon
HCA Healthcare
HCA
+$4.22M
5
THC icon
Tenet Healthcare
THC
+$3.84M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$8.04M
2
CI icon
Cigna
CI
+$6.22M
3
MRK icon
Merck
MRK
+$3.29M
4
PFE icon
Pfizer
PFE
+$3.21M
5
INCY icon
Incyte
INCY
+$3.08M

Sector Composition

Rank Sector Weight
1 Healthcare 67.42%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVNR
51
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
$1.41M 0.66%
250,000
– –
LUMO
52
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.33M 0.62%
+5,556
New +$1.13M
DYAX
53
DELISTED
DYAX CORPORATION
DYAX
$1.13M 0.53%
117,500
+17,500
+18% +$133K
AKAO
54
DELISTED
Achaogen Inc
AKAO
$1.05M 0.49%
75,000
+20,000
+36% +$280K
EGLT
55
DELISTED
Egalet Corporation
EGLT
$984K 0.46%
75,000
-25,000
-25% -$313K
ETRM
56
DELISTED
EnteroMedics Inc.
ETRM
$936K 0.44%
571
-524
-48% -$980K
LJPC
57
DELISTED
La Jolla Pharmaceutical Company
LJPC
$918K 0.43%
100,000
-12,500
-11% -$114K
SRNE
58
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$878K 0.41%
130,000
+80,000
+160% +$603K
ASRT
59
PUT
DELISTED
Assertio
ASRT
$695K 0.32%
+833
New +$642K
FLXN
60
DELISTED
Flexion Therapeutics, Inc.
FLXN
$674K 0.31%
50,000
-40,000
-44% -$545K
NUWE icon
61
Nuwellis
NUWE
$539K
– –
0
– –
NUWE icon
62
CALL
Nuwellis
NUWE
$539K
– –
0
– –
AVDL
63
DELISTED
Avadel Pharmaceuticals
AVDL
$375K 0.17%
+25,000
New +$302K
SVRA icon
64
Savara
SVRA
$1.14B
$315K 0.15%
7,143
– –
BAX icon
65
PUT
Baxter International
BAX
$14.4B
– –
-92,050
Closed -$3.68M
BMRN icon
66
CALL
BioMarin Pharmaceuticals
BMRN
$13.4B
– –
-40,000
Closed -$2.73M
BRKR icon
67
Bruker
BRKR
$8.75B
– –
-75,000
Closed -$1.71M
CLDX icon
68
CALL
Celldex Therapeutics
CLDX
$3.48B
– –
-3,333
Closed -$884K
BGMS
69
Bio Green Med Solution Inc
BGMS
$4.97M
– –
0
– -$920K
CYTK icon
70
CALL
Cytokinetics
CYTK
$10.7B
– –
-361,500
Closed -$3.43M
CYTK icon
71
Cytokinetics
CYTK
$10.7B
– –
-280,000
Closed -$2.66M
GILD icon
72
CALL
Gilead Sciences
GILD
$169B
– –
-15,000
Closed -$1.06M
HOLX
73
CALL
DELISTED
Hologic
HOLX
– –
-40,000
Closed -$860K
INCY icon
74
Incyte
INCY
$24.5B
– –
-57,500
Closed -$3.08M
INSM icon
75
CALL
Insmed
INSM
$28.8B
– –
-60,000
Closed -$1.14M
1 2
3
4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2014 Portfolio in Review

As of Q2 2014, Iguana Healthcare Management held 99 positions worth $214M, down 0.89% from $216M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Iguana Healthcare Management withdrew a net $12M in Q2 2014, closing 34 positions and reducing 21 holdings. Its most notable exit was Zimmer Biomet, an estimated $8.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 65% a quarter earlier, followed by Industrials.

Against the trend, Iguana Healthcare Management opened a new position in Celgene Corp worth $9.02M.

  • Iguana Healthcare Management's largest Q2 2014 buy was Celgene Corp: 105,000 shares worth $9.02M.
  • Iguana Healthcare Management added most to Medtronic in Q2 2014, an estimated $2.58M increase.
  • Iguana Healthcare Management's biggest Q2 2014 reduction was Cigna, cutting an estimated $6.22M.
  • Iguana Healthcare Management fully exited Zimmer Biomet in Q2 2014, selling an estimated $8.04M.
  • Iguana Healthcare Management's ten largest holdings make up 39% of its $214M portfolio in Q2 2014.
  • Iguana Healthcare Management opened 24 new positions and closed 34 in Q2 2014.
  • Iguana Healthcare Management's portfolio value fell 0.89% quarter-over-quarter to $214M.

Based on Iguana Healthcare Management's 13F filing for Q2 2014, filed 14 Aug 2014.